Return to site

Cardiac Surgery Instruments Market is expected to reach USD 1.63 Billion by 2022

Cardiac Surgery Instruments Market by Product (Clamps, Forceps, Scalpel, Scissors, Needle Holder), Application (Coronary Artery Bypass Graft, Heart Valve Surgery, Pediatric Surgery, Heart Transplant), & End User (Hospital, ASC) - Global Forecast to 2022

· Medical Devices,Biotechnology,Healthcare

North America dominated the global cardiac surgery instruments market in 2017, with the U.S. accounting for a major share of this regional market. Factors such as high incidence of cardiac diseases, rising awareness programs and increased funding for research projects are likely to drive the growth of the North American market.

The overall cardiac surgery instruments market is expected to reach USD 1.63 Billion by 2022 from USD 1.16 Billion in 2017 at a CAGR of 7.1%.

Major Key Players of the Cardiac Surgery Instruments Market are:
Key players in this market include Becton, Dickinson and Company (U.S.), B. Braun Melsungen AG (Germany), Teleflex Incorporated (U.S.), Medline Industries, Inc. (U.S.), KLS Martin Group (U.S.), STILLE (Sweden), Sklar Surgical Instruments (U.S.), Symmetry Surgical Inc. (U.S.), Delacroix-Chevalier (France), Wexler Surgical (U.S.), Surgins (U.K.), Surtex Instruments Ltd. (U.K.), Cardivon Surgical Inc. (China), Rumex International Corporation (U.S.), and Scanlan International (U.S.).

Cardiac Surgery Instruments Market, by Application

  • Coronary Artery Bypass Graft (CABG)
  • Heart Valve Surgery
  • Pediatric Cardiac Surgery
  • Other Applications

Note: Other applications include heart transplant and cardiomyoplasty.

The market is further divided into coronary artery bypass graft (CABG), heart valve surgery, pediatric cardiac surgery, and other applications. CABG forms the largest and fastest-growing application segment of the global market. This is mainly attributed to the high incidence of cardiac diseases and the resulting increase in the number of surgical procedures. Heart valve surgery forms the second largest segment.

The global cardiac surgery equipment market is dominated by North America, followed by Europe. The market in Asia is expected to grow at the highest CAGR during the forecast period. Factors such as increasing awareness programs, high incidence of cardiac diseases, rising number of hospitals, increased cardiac research funding, and improvements in the healthcare sector of Asian countries contribute to the growth of the market in that region.

All Posts
×

Almost done…

We just sent you an email. Please click the link in the email to confirm your subscription!

OKSubscriptions powered by Strikingly